UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Catalogue
Articles
RSS feedX
Search Filters
Format
Subjects
Language
Publication DateThe FASEB journal, ISSN 0892-6638, 09/2017, Volume 31, Issue 9, pp. 3848 - 3857
UDCA | epithelium | HβD | innate immunity | Innate immunity | HbD | Epithelium | Biochemistry & Molecular Biology | Biology | Life Sciences & Biomedicine - Other Topics | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Colon - cytology | Cell Line | Ursodeoxycholic Acid - administration & dosage | beta-Defensins - genetics | Receptors, G-Protein-Coupled - metabolism | Tissue Culture Techniques | Humans | RNA, Messenger - genetics | NF-kappa B - metabolism | Epithelial Cells | beta-Defensins - secretion | RNA, Messenger - metabolism | Mice, Knockout | Dose-Response Relationship, Drug | Intestinal Mucosa - cytology | Ursodeoxycholic Acid - pharmacology | Animals | Deoxycholic Acid - pharmacology | NF-kappa B - genetics | Deoxycholic Acid - administration & dosage | Mice | Receptors, G-Protein-Coupled - genetics | beta-Defensins - metabolism | NF-κB protein | Phosphorylation | G protein-coupled receptors | Bile acids | Epithelial cells | Secretion | Mucosa | Ursodeoxycholic acid | Deoxycholic acid | Acids | Defensins | Intestine | Animal tissues | Colon | Inhibition | Bile | Index Medicus | Life Sciences
Journal Article
Details 
Digital rights
Loading RightsMolecular metabolism (Germany), ISSN 2212-8778, 04/2019, Volume 22, pp. 96 - 109
Gut microbiota | Obesity | Dietary intervention | High-fat diet | Synbiotics | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Animals | Obesity - chemically induced | Mice, Inbred C57BL | Gastrointestinal Microbiome | Diet, High-Fat - adverse effects | Male | Mice, Obese | Mice | Obesity - metabolism | Index Medicus
Journal Article
Details
Digital rights
Loading RightsJournal of hepatology, ISSN 0168-8278, 2015, Volume 62, Issue 6, pp. 1398 - 1404
Gastroenterology and Hepatology | 3-hydroxy-3-methylglutaryl-CoA reductase | Stearoyl-CoA desaturase | Non-alcoholic fatty liver disease | Lipogenesis | FGF19 | 3-hydroxy-3-methylglutaryl- CoA reductase | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Ursodeoxycholic Acid - administration & dosage | Oleic Acid - metabolism | Bile Acids and Salts - biosynthesis | Humans | Liver - metabolism | Bile Acids and Salts - metabolism | Non-alcoholic Fatty Liver Disease - metabolism | Intra-Abdominal Fat - metabolism | Obesity, Morbid - drug therapy | Non-alcoholic Fatty Liver Disease - drug therapy | Ursodeoxycholic Acid - pharmacology | Stearoyl-CoA Desaturase - biosynthesis | Liver - drug effects | Receptors, Cytoplasmic and Nuclear - antagonists & inhibitors | Lipid Metabolism - drug effects | Intra-Abdominal Fat - drug effects | Obesity, Morbid - metabolism | Physiological aspects | Obesity | Ursodiol | Deoxycholic acid | Index Medicus | BAs, bile acids | nCEH, neutral cholesterol ester hydrolase | ApoB, apolipoprotein B | LDLR, low density lipoprotein receptor | FGF19, fibroblast growth factor 19 | VLDL, very low density lipoproteins | ABC, ATP-binding cassette | TGs, triglycerides | NAFLD, non-alcoholic fatty liver disease | OA, oleic acid | C4, 7α-hydroxy-4-cholesten-3-one | SHP, small heterodimer partner | SREBP1c, sterol regulatory element-binding protein-1c | CA, cholic acid | PA, palmitic acid | FATP1, fatty acid transport protein 1 | UDCA, ursodeoxycholic acid | FAs, fatty acides | HMGCR, 3-hydroxy-3-methylglutaryl-CoA reductase | vWAT, visceral white adipose tissue | SCD, stearoyl-Coa desaturase | CYP7A1, cholesterol 7α-hydroxylase | NASH, non-alcoholic steatohepatitis | FXR, farnesoid X receptor | CDCA, chenodeoxycholic acid | MA, myristic acid | FASN, fatty acid synthase | MTTP, microsomal triglyceride transfer protein | SA, stearic acid | NONALCOHOLIC | FATTY LIVER-DISEASE | NUCLEAR RECEPTOR | CHOLESTEROL-METABOLISM | TRANSPORT | Endokrinologi och diabetes | FEEDBACK-REGULATION | STEATOHEPATITIS | PLACEBO-CONTROLLED TRIAL | COA DESATURASE | EXPRESSION | Endocrinology and Diabetes | ADIPOSE-TISSUE
Journal Article
Details
Digital rights
Loading RightsAlimentary pharmacology & therapeutics, ISSN 0269-2813, 11/2018, Volume 48, Issue 9, pp. 1034 - 1035
Journal Article
Details
Digital rights
Loading RightsClinical gastroenterology and hepatology, ISSN 1542-3565, 2017, Volume 15, Issue 5, pp. 720 - 727.e1
Gastroenterology and Hepatology | CDCA | Lithocholate | Clinical Study | Intestine | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Cross-Sectional Studies | Colon - pathology | Humans | Middle Aged | Male | Minnesota | Diarrhea - pathology | Gastrointestinal Transit | Feces - chemistry | Irritable Bowel Syndrome - pathology | Adult | Female | Bile Acids and Salts - analysis | Lipids - analysis | Diarrhea | Care and treatment | Continuing medical education | Epidemiology | Irritable bowel syndrome | Deoxycholic acid | Medicine, Experimental | Medical research | Index Medicus | clinical study | intestine | lithocholate
Journal Article
Details
Digital rights
Loading RightsJournal of hepatology, ISSN 0168-8278, 2012, Volume 58, Issue 1, pp. 155 - 168
Gastroenterology and Hepatology | Gallstones | Liver cancer | Bile acids | Fatty liver disease | Cholestasis | Liver regeneration | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Animals | Carrier Proteins - metabolism | Cholestasis - metabolism | Membrane Glycoproteins - metabolism | Humans | Liver - metabolism | Bile Acids and Salts - metabolism | Liver Diseases - metabolism | Liver Regeneration - physiology | Receptors, Cytoplasmic and Nuclear - metabolism | Drug resistance in microorganisms | Corticosteroids | Glucagon | Calcifediol | Ursodiol | Deoxycholic acid | Epidermal growth factor | Vitamin D | Physiological aspects | Fibroblast growth factors | Alfacalcidol | Index Medicus | IBABP (FABP6, ILBP), intestinal bile acid-binding protein, fatty acid-binding protein 6 | PFIC, progressive familial intrahepatic cholestasis | TNFα, tumor necrosis factor α | 3 (human) | SRC2, p160 steroid receptor coactivator | NAFLD, non-alcoholic fatty liver disease | BA, bile acid | bile acid receptor | 8, cholesterol efflux pump, ATP-binding cassette, subfamily G, member 5 | UDCA, ursodeoxycholic acid | LRH-1 (NR5A2), liver receptor homolog-1 | LCA, lithocholic acid | LXRα (NR1H3), liver X receptor alpha | PPARγ (NR1C3), peroxisome proliferator-activated receptor gamma | OSTαβ, organic solute transporter alpha | ABCG5 | AMPK, AMP activated protein kinase | NASH, non-alcoholic steatohepatitis | SHP (NR0B2), short heterodimer partner | OATP1A2 (SLCO1A2, OATP1, OATP-A, SLC21A3), solute carrier organic anion transporter family, member 1A2 | EGFR, epidermal growth factor receptor | IL6, interleukin 6 | TGR5, G protein-coupled bile acid receptor | PH, partial hepatectomy | AE2, anion exchanger 2 | PSC, primary sclerosing cholangitis | OATP1B1 (SLCO1B1, OATP2, OATP-C, SLC21A6), solute carrier organic anion transporter family, member 1B1 | RARα (NR1B1), retinoic acid receptor alpha | GLP-1, glucagon like peptide 1 | VDR (NR1I1), vitamin D receptor. Please note that for the convenience of better readability and clarity, abbreviations for transporters and nuclear receptors were capitalized throughout this article when symbols were identical for human and rodents | MRP2 (ABCC2), multidrug resistance-associated protein 2, ATP-binding cassette, subfamily C, member 2 | NTCP (SLC10A1), sodium | CAR (NR1I3), constitutive androstane receptor | taurocholate cotransporting polypeptide, solute carrier family 10, member 1 | PPARα (NR1C1), peroxisome proliferator-activated receptor alpha | Review | GR (NR3C1), glucocorticoid receptor | Bile acids, Cholestasis, Fatty liver disease, Gallstones, Liver regeneration, Liver cancer | 19, fibroblast growth factor 15 | Mdr2 | ICP, intrahepatic cholestasis of pregnancy | BRIC, benign recurrent intrahepatic cholestasis | OATP1B3 (SLCO1B3, OATP8, SLC21A8), solute carrier organic anion transporter family, member 1B3 | MRP3 (ABCC3), multidrug resistance-associated protein 3, ATP-binding cassette, subfamily C, member 3 | beta | MDR1 (ABCB1), p-glycoprotein, ATP-binding cassette, subfamily B, member 1 | norUDCA, norursodeoxycholic acid | 6-ECDCA, 6-ethylchenodeoxycholic acid | FXR (NR1H4), farnesoid X receptor | BCRP (ABCG2), breast cancer resistance protein, ATP-binding cassette, subfamily G, member 2 | HNF4α (NR2A1), hepatocyte nuclear factor 4 alpha | PBC, primary biliary cirrhosis | MDR3 (ABCB4), multidrug resistance protein 2 (rodents) | HNF1α, hepatocyte nuclear factor 1 alpha | NR, nuclear receptor | FGF15 | RXRα (NR2B1), retinoid X receptor alpha | PXR (NR1I2), pregnane X receptor | BSEP (ABCB11), bile salt export pump | HCC, hepatocellular carcinoma | MRP4 (ABCC4), multidrug resistance-associated protein 4, ATP-binding cassette, subfamily C, member 4 | TPN, total parenteral nutrition
Journal Article
Details
Digital rights
Loading RightsChemosphere (Oxford), ISSN 0045-6535, 12/2020, Volume 260, pp. 127622 - 127622
Bile acid production | Pericardial edema | Yolk sac and spinal deformity | Heart development | Fluorene-1-carboxylic acid | Environmental Sciences & Ecology | Life Sciences & Biomedicine | Science & Technology | Environmental Sciences | Embryonic development | Developmental biology | Genes | Mortality | Cytochrome P-450 | Physiological aspects | Fluorides | Gene expression | Deoxycholic acid | Index Medicus
Journal Article
Details
Digital rights
Loading Rights